Most Recent
ASIC takes ‘wolf’ trader Tyson Scholz to court
The Australian Securities and Investments Commission has launched court proceedings against the self-proclaimed 'wolf' of the ASX, social media celebrity Tyson Scholz for allegedly providing financial services without a licence.
UniLodge targeted in underpayments class action investigation
Unilodge Australia faces a potential class action alleging the student housing agency shortchanged staff by paying them under the wrong award.
$3.4M lawsuit filed over Melbourne’s North East Link Project
Construction company Delcon Civil is facing a lawsuit by a subcontractor seeking over $3.4 million in damages for alleged breach of contract relating to work on the North East Link project.
‘Full-blooded’ fight brewing between competing a2 Milk class actions
A “full-blooded carriage fight” is set down for next year between two competing class actions alleging dairy giant a2 Milk misled shareholders with an overly optimistic prediction of its infant formula sales.
Deloitte can’t dodge client’s fraud claims, 16 years after alleged conduct
Accounting giant Deloitte has lost its bid to throw out a former client's lawsuit alleging negligence and fraud over a failed interposition under tax law that occurred more than 16 years ago.
ACCC staff training ‘inadequate’ during bank cartel probe, court hears
A senior ACCC officer has been grilled on whether staff training on criminal cartel investigations was “inadequate” while the competition regulator ran a cartel probe into ANZ’s $2.5 billion share placement in 2016.
Qantas in court battle over failed $35M flight academy partnership
Qantas is locked in a legal battle with a US-based pilot training provider over failed negotiations concerning the development of a $35 million pilot academy in regional Queensland.
Biogen may sue third generic drug maker to protect MS drug Tecfidera
Swiss pharmaceutical company Biogen is considering a third patent infringement lawsuit against a drug maker to shield its monopoly in Australia for blockbuster multiple sclerosis drug Tecfidera from generic competition.
ACCC launches case against Booktopia over ‘misleading’ refund policy
The Australian Competition and Consumer Commission has launched proceedings against online book retailer Booktopia for allegedly making false or misleading statements about consumers' rights to refunds for faulty books.
ANZ to pay $25M for short-changing half a million customers
The Australia and New Zealand Banking Group has agreed to pay a $25 million penalty to resolve proceedings by the Australian Securities and Investments Commission alleging the bank short-changed hundreds of thousands of customers to the tune of $200 million.